Reproductive Health & Justice FOIA Request Filed Seeking Transparency in FDA’s Mifepristone Study Procurement Process June 30, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been filed with the Food and Drug Administration (FDA) seeking comprehensive documentation related to the solicitation and contract award procedures for the…
Reproductive Health & Justice FOIA Request Filed for Transparency in FDA’s Mifepristone Study Procurement Process June 17, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on June 9, 2026, to the Food and Drug Administration (FDA) seeking detailed information concerning the solicitation and contract award processes…
Reproductive Health & Justice FOIA Request Filed for Comprehensive Mifepristone Safety Data Amid Evolving Regulatory Scrutiny April 16, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on March 20, 2026, seeking a broad spectrum of safety data related to mifepristone, a medication widely used in medication abortion…
